Pubblicazioni

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomibâdexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study

2017 - LEUKEMIA

Ludwig, H; Weisel, K.; Petrucci, M. T.; Leleu, X.; Cafro, A. M.; Garderet, L.; Leitgeb, C.; Foa, Roberto; Greil, R.; Yakoub Agha, I.; Zboralski, D.; VaulÃ©on, S.; DÃ¼mmler, T.; Beyer, D.; Kruschinski, A.; Riecke, K.; Baumann, M.; Engelhardt, M.

Pubblicazioni

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomibâdexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomibâdexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study